Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

INTRODUCTION: The incidence of herpes zoster (HZ) rises steeply after the age of 50 years and the number of HZ cases and complications such as postherpetic neuralgia (PHN) is predicted to increase because of the ageing population. The objective of this study was to estimate the cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522608/
https://www.ncbi.nlm.nih.gov/pubmed/30929219
http://dx.doi.org/10.1007/s13555-019-0291-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522608/
https://www.ncbi.nlm.nih.gov/pubmed/30929219
http://dx.doi.org/10.1007/s13555-019-0291-4

Ejemplares similares